reference/17367866

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17367866

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article
endingPage	54
issn	0250-7005
issueIdentifier	2B
pageRange	1349-54
publicationName	Anticancer research
startingPage	1349
bibliographicCitation	Tsoutsou PG, Froudarakis ME, Bouros D, Koukourakis MI. Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC). Anticancer Res. 2008 Mar;28(2B):1349–54. PMID: 18505077.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a09eac458263d76483ae7d3ba9e8475b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aef6016a1312a93c1234b0420494c3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afb7ef8dbba7ab67f071f289e67598e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9d5d81b0cbe1627fc041619094e1641
date	200803
identifier	https://pubmed.ncbi.nlm.nih.gov/18505077
isPartOf	https://portal.issn.org/resource/ISSN/0250-7005 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/592
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC)
discusses	http://id.nlm.nih.gov/mesh/M0018387 http://id.nlm.nih.gov/mesh/M0022672 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0097344 http://id.nlm.nih.gov/mesh/M0007867
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000532 http://id.nlm.nih.gov/mesh/D011837Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D004999Q000627 http://id.nlm.nih.gov/mesh/D008175Q000532 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011837Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D014747Q000031 http://id.nlm.nih.gov/mesh/D005240 http://id.nlm.nih.gov/mesh/D000077235 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D004999Q000009 http://id.nlm.nih.gov/mesh/D004317Q000009 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014747Q000009 http://id.nlm.nih.gov/mesh/D014747Q000008 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D019583 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004317Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296871 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10051 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73265388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5672 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2141 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931011 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60780 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13200033 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7655

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128288519

Total number of triples: 65.